BWAY
BrainsWay Ltd.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Last price
14.74
▼ 0.23 (1.54%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
14.86
Prev close
14.97
Day high
15.16
Day low
14.68
Volume
47.34K
Market cap
$592.39M
P/E (TTM)
64.09
52W range
7.14 – 17.40
Day trading desk
Gap from prior close
-0.73%
Prior close 14.97
VWAP
14.79
-0.36% from price
Relative volume
0.34×
Quiet session
Session range
3.27%
14.68 – 15.16
Position in range
12%
Near session low
ATR (14D)
0.88
6.00% of price
Prior day high
15.33
PDH
Prior day low
14.84
PDL
Bid / ask spread
—
Quote not published
Session volume
42.16K
Avg 124.51K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-9.68%
-8.3%
1M
-10.72%
-14.5%
3M
-2.25%
-5.4%
6M
+22.22%
+11.2%
YTD
+54.99%
+42.7%
1Y
+99.59%
+79.6%
3Y
+863.40%
+789.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BWAY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
986.05K
Total on file
Fundamentals
Market cap$592.39M
Enterprise value$515.67M
Revenue (TTM)$60.70M
Gross profit$45.72M
EBITDA$8.48M
Net income$9.44M
EPS (TTM)$0.23
Free cash flow$-6.16M
Total cash$62.11M
Total debt$7.13M
Book value / share$2.05
Shares outstanding40.19M
Float23.20M
Short % of float0.38%
Dividend yield—
Beta (5Y)0.10
Valuation & profitability ratios
Trailing P/E64.09
Forward P/E30.29
PEG ratio—
Price / sales—
Price / book7.21
EV / revenue8.50
EV / EBITDA60.79
Gross margin75.32%
Operating margin13.98%
Profit margin15.55%
Return on equity12.82%
Return on assets4.05%
Debt / equity9.01
Current ratio3.59
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $52.23M | $41.02M | $31.79M | $27.18M | — | +27.3% |
| Operating revenue | $52.23M | $41.02M | $31.79M | $27.18M | — | +27.3% |
| Cost of revenue | $12.84M | $10.44M | $8.31M | $7.13M | — | +23.0% |
| Gross profit | $39.39M | $30.58M | $23.48M | $20.05M | — | +28.8% |
| Research & development | $9.60M | $7.19M | $6.67M | $7.68M | — | +33.6% |
| Selling, general & admin | $25.46M | $22.00M | $21.64M | $24.32M | — | +15.7% |
| Total operating expense | $35.06M | $29.19M | $28.44M | $32.73M | — | +20.1% |
| Operating income | $4.32M | $1.39M | -$4.96M | -$12.68M | — | +210.8% |
| Net interest income | $3.39M | $2.07M | $1.30M | -$107.00K | — | +63.8% |
| Pre-tax income | $7.71M | $3.46M | -$3.95M | -$13.03M | — | +122.9% |
| Tax provision | $77.00K | $538.00K | $251.00K | $315.00K | — | -85.7% |
| Net income | $7.63M | $2.92M | -$4.20M | -$13.35M | — | +161.3% |
| Net income to common | $7.63M | $2.92M | -$4.20M | -$13.35M | — | +161.3% |
| Basic EPS | — | 0.09 | -0.13 | -0.40 | -0.21 | — |
| Diluted EPS | — | 0.09 | -0.13 | -0.40 | -0.21 | — |
| EBIT | $9.92M | $4.97M | -$3.90M | -$12.99M | — | +99.4% |
| EBITDA | $11.46M | $6.75M | -$2.56M | -$11.45M | — | +69.8% |
| Basic shares | 38.16M | 32.46M | 32.28M | 33.37M | — | +17.6% |
| Diluted shares | 42.41M | 32.46M | 32.28M | 33.37M | — | +30.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $67.70M | $69.34M | $10.52M | $47.58M | -2.4% |
| Cash & short-term investments | $69.13M | $69.34M | $45.98M | $47.58M | -0.3% |
| Accounts receivable | $4.11M | $4.60M | $3.78M | $4.84M | -10.6% |
| Inventory | $7.13M | $4.43M | $3.72M | $3.84M | +61.2% |
| Total current assets | $84.89M | $79.67M | $55.47M | $58.09M | +6.6% |
| Property, plant & equipment | $12.17M | $11.95M | $5.79M | $5.35M | +1.8% |
| Total assets | $112.92M | $94.32M | $62.97M | $64.48M | +19.7% |
| Total current liabilities | $22.16M | $15.35M | $9.76M | $8.14M | +44.4% |
| Total debt | $6.82M | $5.62M | $471.00K | $488.00K | +21.2% |
| Total liabilities | $39.70M | $32.00M | $21.39M | $19.08M | +24.0% |
| Retained earnings | -$90.75M | -$98.38M | -$101.30M | -$97.11M | +7.8% |
| Shareholder equity | $73.22M | $62.31M | $41.58M | $45.40M | +17.5% |
| Working capital | $62.73M | $64.32M | $45.70M | $49.95M | -2.5% |
| Net tangible assets | $73.22M | $62.31M | $41.58M | $45.40M | +17.5% |
| Shares issued | 39.16M | 37.63M | 33.24M | 33.05M | +4.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $7.63M | $2.92M | -$4.20M | -$13.35M | — | +161.3% |
| Depreciation & amortisation | $1.54M | $1.77M | $1.34M | $1.53M | — | -13.2% |
| Stock-based compensation | $1.20M | $1.44M | $381.00K | $1.47M | — | -17.0% |
| Change in working capital | $7.59M | $2.39M | $1.64M | -$1.45M | — | +217.8% |
| Operating cash flow | $18.02M | $10.30M | $1.28M | -$9.76M | — | +75.0% |
| Capital expenditure | -$1.75M | -$3.79M | -$2.39M | — | -$2.24M | +54.0% |
| Investing cash flow | -$17.49M | $30.31M | -$37.41M | $42.17M | — | -157.7% |
| Share buybacks | — | $0 | $0 | -$52.00K | — | — |
| Financing cash flow | -$2.21M | $18.26M | -$1.03M | -$1.55M | — | -112.1% |
| Free cash flow | $16.27M | $6.50M | -$1.10M | -$9.76M | — | +150.2% |
| End cash position | $67.70M | $69.34M | $10.52M | $47.58M | — | -2.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $15.53M | $14.54M | $13.51M | $12.63M | $11.54M | +6.8% |
| Operating revenue | $15.53M | $14.54M | $13.51M | $12.63M | $11.54M | +6.8% |
| Cost of revenue | $3.86M | $3.43M | $3.35M | $3.13M | $2.93M | +12.5% |
| Gross profit | $11.68M | $11.12M | $10.16M | $9.50M | $8.61M | +5.0% |
| Research & development | $2.88M | $2.53M | $2.40M | $2.34M | $2.33M | +13.8% |
| Selling, general & admin | $6.79M | $6.67M | $6.51M | $6.58M | $5.70M | +1.8% |
| Total operating expense | $9.67M | $9.20M | $8.91M | $8.92M | $8.03M | +5.1% |
| Operating income | $2.00M | $1.92M | $1.25M | $578.00K | $576.00K | +4.6% |
| Net interest income | $405.00K | $625.00K | $555.00K | $1.52M | $688.00K | -35.2% |
| Pre-tax income | $2.41M | $2.54M | $1.81M | $2.10M | $1.26M | -5.2% |
| Tax provision | $120.00K | -$392.00K | $242.00K | $70.00K | $157.00K | +130.6% |
| Net income | $2.29M | $2.93M | $1.57M | $2.03M | $1.11M | -21.9% |
| Net income to common | $2.29M | $2.93M | $1.57M | $2.03M | $1.11M | -21.9% |
| Basic EPS | 0.06 | 0.08 | 0.04 | 0.05 | 0.03 | -25.0% |
| Diluted EPS | 0.06 | 0.07 | 0.04 | 0.05 | 0.02 | -14.3% |
| EBIT | $2.73M | $2.97M | $2.38M | $2.88M | $1.85M | -8.2% |
| EBITDA | $3.19M | $3.32M | $2.78M | $3.27M | $2.24M | -3.9% |
| Basic shares | 38.17M | 36.66M | 39.15M | 40.54M | 36.90M | +4.1% |
| Diluted shares | 38.17M | 41.90M | 39.15M | 40.54M | 36.90M | -8.9% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $58.64M | $67.70M | $70.46M | $67.91M | $71.60M | -13.4% |
| Cash & short-term investments | $59.77M | $69.13M | $71.54M | $78.00M | $71.60M | -13.5% |
| Accounts receivable | $7.53M | $4.11M | $5.13M | $3.87M | $6.95M | +83.2% |
| Inventory | $7.08M | $7.13M | $4.42M | $4.19M | $4.68M | -0.8% |
| Total current assets | $78.63M | $84.89M | $82.93M | $89.49M | $84.66M | -7.4% |
| Property, plant & equipment | $12.91M | $12.17M | $14.02M | $13.17M | $12.24M | +6.1% |
| Total assets | $117.00M | $112.92M | $113.06M | $111.56M | $100.20M | +3.6% |
| Total current liabilities | $23.55M | $22.16M | $25.99M | $25.51M | $16.85M | +6.3% |
| Total debt | $6.71M | $6.82M | $6.75M | $6.13M | $5.57M | -1.6% |
| Total liabilities | $41.20M | $39.70M | $43.00M | $43.43M | $36.45M | +3.8% |
| Retained earnings | -$88.52M | -$90.75M | -$93.68M | -$95.25M | -$97.27M | +2.5% |
| Shareholder equity | $75.80M | $73.22M | $70.06M | $68.13M | $63.75M | +3.5% |
| Working capital | $55.07M | $62.73M | $56.94M | $63.98M | $67.81M | -12.2% |
| Net tangible assets | $75.80M | $73.22M | $70.06M | $68.13M | $63.75M | +3.5% |
| Shares issued | 40.03M | 39.16M | 38.01M | 37.79M | 37.74M | +2.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $2.29M | $2.93M | $1.57M | $2.03M | $1.11M | — | -21.9% |
| Depreciation & amortisation | $465.00K | $352.00K | $404.00K | $388.00K | $394.00K | — | +32.1% |
| Stock-based compensation | $342.00K | $280.00K | $364.00K | $227.00K | $325.00K | — | +22.1% |
| Change in working capital | -$1.76M | -$4.15M | -$1.95M | $10.99M | $2.69M | — | +57.6% |
| Operating cash flow | $1.17M | -$759.00K | $1.39M | $12.38M | $5.01M | — | +254.3% |
| Capital expenditure | -$769.00K | — | -$800.00K | -$1.17M | -$1.04M | -$923.00K | — |
| Investing cash flow | -$9.33M | -$1.03M | $1.36M | -$15.86M | -$1.97M | — | -802.9% |
| Financing cash flow | -$901.00K | -$987.00K | -$208.00K | -$264.00K | -$755.00K | — | +8.7% |
| Free cash flow | $402.00K | -$759.00K | $586.00K | $11.22M | $3.97M | — | +153.0% |
| End cash position | $58.64M | $67.70M | $70.46M | $67.91M | $71.60M | — | -13.4% |
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.50
Positioning, not flow
Max pain
15.00
+1.8% from spot
ATM implied vol
91.8%
Nearest strike to spot
Skew (10% OTM)
+15.0%
Puts bid over calls
Call volume
8
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
17.50
2 contracts
Heaviest put OI
15.00
2 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.07 | 0.07 | -4.5% |
| Mar 2026 | 0.05 | 0.06 | +20.0% |
| Dec 2025 | 0.03 | 0.06 | +155.4% |
| Sep 2025 | 0.02 | 0.02 | -14.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.07 | 2 | $17.64M | +30.6% |
| Next quarter | 0.08 | 2 | $18.69M | +28.5% |
| Current year | 0.27 | 2 | $68.73M | +31.6% |
| Next year | 0.49 | 3 | $84.08M | +22.3% |
Analyst targets & ownership
Mean target$18.60
High target$20.00
Low target$17.00
Implied upside26.19%
Analyst count3
ConsensusSTRONG BUY
Strong buy / Buy0 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders2.55%
Held by institutions32.48%
Institutions holding71
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
15.47
-4.73% from price
SMA 20
15.42
-4.40% from price
SMA 50
15.21
-3.11% from price
SMA 100
15.22
-3.18% from price
SMA 200
12.94
+13.88% from price
EMA 12
15.33
-3.84% from price
EMA 26
15.39
-4.22% from price
EMA 50
15.28
-3.56% from price
RSI (14)
44.7
Neutral
MACD (12,26,9)
-0.06
Hist -0.12
ATR (14)
0.88
6.00% of price
Realised vol 30D
66.3%
Annualised
Bollinger upper
16.61
20, 2σ
Bollinger lower
14.23
20, 2σ
50 / 200 cross
Golden
15.21 vs 12.94
Trend bias
Above 200
+13.88%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.93
More volatile than market
Correlation to SPY
0.46
Loosely linked
Realised vol 30D
66.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-19.1%
Peak to trough
Max drawdown 5Y
-83.7%
Peak to trough
ATR 14
0.88
6.00% of price
Beta (reported)
0.10
5Y monthly, from filing
Short interest
Shares short
116.52K
Prior 183.71K
Change vs prior
-36.6%
Shorts covering
% of float
0.38%
Normal
% of shares out
0.29%
Against total outstanding
Days to cover
0.9
Liquid
Float
23.20M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 26 | Ladenburg Thalmann | MAINTAINED | Buy | Buy |
| Aug 12, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 20, 26 | BTIG | INITIATED | — | Buy |
| Jul 2, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 15, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 26, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Mar 12, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jan 26, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Dec 8, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 13, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 12, 25 | Northland Capital Markets | MAINTAINED | Outperform | Outperform |
| Aug 25, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateMar 4, 2026
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-08-12
Corporate Changes & Voting Matters
6-K · 2026-07-20
Corporate Changes & Voting Matters
6-K · 2026-07-16
Corporate Changes & Voting Matters
6-K · 2026-06-29
Corporate Changes & Voting Matters
6-K · 2026-06-22
Corporate Changes & Voting Matters
6-K · 2026-06-09
Corporate Changes & Voting Matters
6-K · 2026-05-18
Corporate Changes & Voting Matters
6-K · 2026-05-13
Headlines
Brainsway (BWAY) Upgraded to Buy: Here's Why
Zacks · 6d ago
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?
Zacks · 6d ago
Brainsway Q2 Earnings Call Highlights
MarketBeat · 10d ago
BrainsWay Ltd (BRSYF) (Q2 2026) Earnings Call Highlights: Revenue Surges 35% to $17. ...
GuruFocus.com · 11d ago
BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
GlobeNewswire · 11d ago
Earnings To Watch: BrainsWay Ltd (BWAY) Q2 2026 -- GF Value Sees 35% Downside
GuruFocus.com · 12d ago
BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026
GlobeNewswire · 25d ago
Brainsway and Lululemon athletica have been highlighted as Zacks Bull and Bear of the Day
Zacks · 30d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.